Baseline characteristics (n = 17)

Baseline characteristicsn (% or range)
Age66 (45–79)
Baseline PSA (ng/mL)79.7 (3.9–2356)
Baseline Hemoglobin (g/dL)12.2 (9.3–14.5)
Baseline LDH (U/L)241 (153–351)
Baseline Alkaline Phosphatase (U/L)80 (56–643)
Baseline CTCs (in 10 mL blood)12 (0–2107)
Prior treatment with:
 Enzalutamide16 (94%)
 Abiraterone11 (65%)
 Both10 (59%)
 Prior immunotherapy8 (47%)
 Prior chemotherapy11 (65%)
Gleason score
 <  85 (29%)
 8–1012 (71%)
ECOG performance status
 02 (12%)
 114 (82%)
 21 (6%)
Disease site:
 Bone only5 (29%)
 Bone/soft tissue/viscera12 (71%)